For research use only. Not for therapeutic Use.
Fasinumab (Anti-Human NGF) is a human IgG4 monoclonal antibody to nerve growth factor (NGF). Fasinumab can be used in acute sciatica and knee osteoarthritis (OA) studies[1].
| Catalog Number | I043195 |
| CAS Number | 1190239-42-9 |
| Purity | ≥95% |
| Reference | [1]. Paul J Tiseo, et al. Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study. J Pain Res. 2014 Aug 22;7:523-30. |
